authors
- Renouf, DJ
- Hirte, Holger
- O'Bryant, CL
- Trnkova, ZJ
- Cleton, A
- Huang, F
- Mueller, U
- Ayoub, J-P
- Lockhart, AC
- Quinn, DI
- Dy, GK
- Sawyer, MB
A phase 1 study evaluating the pharmacokinetics (PK) and safety of regorafenib (REG) in patients with advanced solid tumors with severe renal impairment (SRI)
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2016
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal